Kite Pharma Reports First Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Kite Pharma Reports First Quarter 2016 Financial Results

Kite Pharma (KITE) Reports Q1 Loss Per Share of 60c

May 9, 2016 4:54 PM EDT

Kite Pharma (NASDAQ: KITE) reported Q1 EPS of ($0.60), $0.48 better than the analyst estimate of ($1.08). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $4.61 million.

"Our ZUMA-1 update at AACR last month highlighted the potential of KTE-C19, our breakthrough immunotherapy candidate,... More